CHICAGO (Reuters) - A clinical trial from Roche Holding AG combining the company's newer targeted drug for breast cancer with an older treatment resulted in a modest benefit for women with a specific type of disease, according to data presented on ...
Zytiga Can Be Paradigm-Shifting for Prostate Cancer Treatment
He said the LATITUDE data “should immediately reshape our treatment algorithms for prostate cancer, and Zytiga with conventional hormone therapy should become a new standard of care for men with high-risk metastatic prostate cancer.” He said the ...
No comments:
Post a Comment